Top

Published in:

01-12-2016 | Article

Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity

Authors: Martin Heni, Stephanie Kullmann, Emma Ahlqvist, Robert Wagner, Fausto Machicao, Harald Staiger, Hans-Ulrich Häring, Peter Almgren, Leif C. Groop, Dana M. Small, Andreas Fritsche, Hubert Preissl

Published in: Diabetologia | Issue 12/2016

Abstract

Aims/hypothesis

Variations in FTO are the strongest common genetic determinants of adiposity, and may partly act by influencing dopaminergic signalling in the brain leading to altered reward processing that promotes increased food intake. Therefore, we investigated the impact of such an interaction on body composition, and peripheral and brain insulin sensitivity.

Methods

Participants from the Tübingen Family study (n = 2245) and the Malmö Diet and Cancer study (n = 2921) were genotyped for FTO SNP rs8050136 and ANKK1 SNP rs1800497. Insulin sensitivity in the caudate nucleus, an important reward area in the brain, was assessed by fMRI in 45 participants combined with intranasal insulin administration.

Results

We found evidence of an interaction between variations in FTO and an ANKK1 polymorphism that associates with dopamine (D2) receptor density. In cases of reduced D2 receptor availability, as indicated by the ANKK1 polymorphism, FTO variation was associated with increased body fat and waist circumference and reduced peripheral insulin sensitivity. Similarly, altered central insulin sensitivity was observed in the caudate nucleus in individuals with the FTO obesity-risk allele and diminished D2 receptors.

Conclusions/interpretation

The effects of variations in FTO are dependent on dopamine D2 receptor density (determined by the ANKK1 polymorphism). Carriers of both risk alleles might, therefore, be at increased risk of obesity and diabetes.

Walley AJ, Asher JE, Froguel P (2009) The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10:431–442. doi:10.1038/nrg2594 CrossRefPubMed

Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894. doi:10.1126/science.1141634 CrossRefPubMedPubMedCentral

Dina C, Meyre D, Gallina S et al (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39:724–726. doi:10.1038/ng2048 CrossRefPubMed

Loos RJF, Yeo GSH (2014) The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol 10:51–61. doi:10.1038/nrendo.2013.227 CrossRefPubMed

Haupt A, Thamer C, Staiger H et al (2009) Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc 117:194–197. doi:10.1055/s-0028-1087176 CrossRef

Cecil JE, Tavendale R, Watt P et al (2008) An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 359:2558–2566. doi:10.1056/NEJMoa0803839 CrossRefPubMed

Wardle J, Carnell S, Haworth CMA et al (2008) Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 93:3640–3643. doi:10.1210/jc.2008-0472 CrossRefPubMed

Heni M, Kullmann S, Veit R et al (2013) Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli in the prefrontal cortex. Mol Metab 3:109–113. doi:10.1016/j.molmet.2013.11.009 CrossRefPubMedPubMedCentral

Karra E, O’Daly OG, Choudhury AI et al (2013) A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest 123:3539–3551. doi:10.1172/JCI44403 CrossRefPubMedPubMedCentral

10.

Staiger H, Machicao F, Fritsche A, Häring H-U (2009) Pathomechanisms of type 2 diabetes genes. Endocr Rev 30:557–585. doi:10.1210/er.2009-0017 CrossRefPubMed

11.

Smemo S, Tena JJ, Kim K-H et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371–375. doi:10.1038/nature13138 CrossRefPubMedPubMedCentral

12.

Claussnitzer M, Dankel SN, Kim K-H et al (2015) FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med 373:895–907. doi:10.1056/NEJMoa1502214 CrossRefPubMedPubMedCentral

13.

Stratigopoulos G, Burnett LC, Rausch R et al (2016) Hypomorphism of Fto and Rpgrip1l causes obesity in mice. J Clin Invest 126:1897–1910. doi:10.1172/JCI85526 CrossRefPubMedPubMedCentral

14.

Hess ME, Hess S, Meyer KD et al (2013) The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 16:1042–1048. doi:10.1038/nn.3449 CrossRefPubMed

15.

Luo S, Luo J, Meier AH, Cincotta AH (1997) Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance. Neuroreport 8:3495–3499CrossRefPubMed

16.

Diepenbroek C, van der Plasse G, Eggels L et al (2013) Alterations in blood glucose and plasma glucagon concentrations during deep brain stimulation in the shell region of the nucleus accumbens in rats. Front Neurosci 7:226. doi:10.3389/fnins.2013.00226 CrossRefPubMedPubMedCentral

17.

Halpern CH, Tekriwal A, Santollo J et al (2013) Amelioration of binge eating by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation. J Neurosci Off J Soc Neurosci 33:7122–7129. doi:10.1523/JNEUROSCI.3237-12.2013 CrossRef

18.

Defronzo RA (2011) Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care 34:789–794. doi:10.2337/dc11-0064 CrossRefPubMedPubMedCentral

19.

Figlewicz DP, Szot P, Chavez M et al (1994) Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 644:331–334CrossRefPubMed

20.

Figlewicz DP, Sipols AJ (2010) ENERGY REGULATORY SIGNALS AND FOOD REWARD. Pharmacol Biochem Behav 97:15–24. doi:10.1016/j.pbb.2010.03.002 CrossRefPubMedPubMedCentral

21.

Speed NK, Matthies HJG, Kennedy JP et al (2010) Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. ACS Chem Neurosci 1:476–481. doi:10.1021/cn100031t CrossRefPubMedPubMedCentral

22.

Palmiter RD (2007) Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30:375–381. doi:10.1016/j.tins.2007.06.004 CrossRefPubMed

23.

Könner AC, Hess S, Tovar S et al (2011) Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab 13:720–728. doi:10.1016/j.cmet.2011.03.021 CrossRefPubMed

24.

Tschritter O, Preissl H, Yokoyama Y et al (2007) Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 50:2602–2603. doi:10.1007/s00125-007-0839-1 CrossRefPubMed

25.

Obici S, Feng Z, Karkanias G et al (2002) Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5:566–572. doi:10.1038/nn861 CrossRefPubMed

26.

Pocai A, Lam TKT, Gutierrez-Juarez R et al (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434:1026–1031. doi:10.1038/nature03439 CrossRefPubMed

27.

Pocai A, Obici S, Schwartz GJ, Rossetti L (2005) A brain-liver circuit regulates glucose homeostasis. Cell Metab 1:53–61. doi:10.1016/j.cmet.2004.11.001 CrossRefPubMed

28.

Heni M, Wagner R, Kullmann S et al (2014) Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 63:4083–4088. doi:10.2337/db14-0477 CrossRefPubMed

29.

Heni M, Kullmann S, Preissl H et al (2015) Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11:701–711. doi:10.1038/nrendo.2015.173 CrossRefPubMed

30.

Do R, Bailey SD, Desbiens K et al (2008) Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 57:1147–1150. doi:10.2337/db07-1267 CrossRefPubMed

31.

Haupt A, Thamer C, Machann J et al (2008) Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obes Silver Spring Md 16:1969–1972. doi:10.1038/oby.2008.283 CrossRef

32.

Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345. doi:10.1126/science.1142382 CrossRefPubMedPubMedCentral

33.

Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540–545. doi:10.1002/humu.20039 CrossRefPubMed

34.

Jönsson EG, Nöthen MM, Grünhage F et al (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290–296CrossRefPubMed

35.

Zhang Y, Bertolino A, Fazio L et al (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104:20552–20557. doi:10.1073/pnas.0707106104 CrossRefPubMedPubMedCentral

36.

Gluskin BS, Mickey BJ (2016) Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Transl Psychiatry 6:e747. doi:10.1038/tp.2016.22 CrossRefPubMedPubMedCentral

37.

Comings DE, Muhleman D, Ahn C et al (1994) The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 34:175–180CrossRefPubMed

38.

Felsted JA, Ren X, Chouinard-Decorte F, Small DM (2010) Genetically determined differences in brain response to a primary food reward. J Neurosci Off J Soc Neurosci 30:2428–2432. doi:10.1523/JNEUROSCI.5483-09.2010 CrossRef

39.

Benton D, Young HA (2016) A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction? Int J Obes 40:S12–S21. doi:10.1038/ijo.2016.9 CrossRef

40.

Winkler JK, Woehning A, Schultz J-H et al (2012) TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutr Burbank Los Angel Cty Calif 28:996–1001. doi:10.1016/j.nut.2011.12.018 CrossRef

41.

Stice E, Spoor S, Bohon C, Small DM (2008) Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322:449–452. doi:10.1126/science.1161550 CrossRefPubMed

42.

Sevgi M, Rigoux L, Kühn AB et al (2015) An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning. J Neurosci Off J Soc Neurosci 35:12584–12592. doi:10.1523/JNEUROSCI.1589-15.2015 CrossRef

43.

Goldstein JI, Crenshaw A, Carey J et al (2012) zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinforma Oxf Engl 28:2543–2545CrossRef

44.

Stefan N, Machicao F, Staiger H et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48:2282–2291. doi:10.1007/s00125-005-1948-3 CrossRefPubMed

45.

Kullmann S, Frank S, Heni M et al (2013) Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women. Neuroendocrinology 97:176–182. doi:10.1159/000341406 CrossRefPubMed

46.

Roth CL, Hinney A, Schur EA et al (2013) Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. BMC Pediatr 13:197. doi:10.1186/1471-2431-13-197 CrossRefPubMedPubMedCentral

47.

Small DM, Zatorre RJ, Dagher A et al (2001) Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain J Neurol 124:1720–1733CrossRef

48.

Small DM, Jones-Gotman M, Dagher A (2003) Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 19:1709–1715CrossRefPubMed

49.

Wagner R, Heni M, Linder K et al (2014) Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol 51:71–78. doi:10.1007/s00592-013-0493-7 CrossRefPubMed

50.

Hallschmid M, Benedict C, Schultes B et al (2004) Intranasal insulin reduces body fat in men but not in women. Diabetes 53:3024–3029CrossRefPubMed

51.

Tschritter O, Preissl H, Hennige AM et al (2012) High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 55:175–182. doi:10.1007/s00125-011-2309-z CrossRefPubMed

Title: Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity
Authors: Martin Heni
Stephanie Kullmann
Emma Ahlqvist
Robert Wagner
Fausto Machicao
Harald Staiger
Hans-Ulrich Häring
Peter Almgren
Leif C. Groop
Dana M. Small
Andreas Fritsche
Hubert Preissl
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 12/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-016-4095-0

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 12/2016

Physical activity and incident type 2 diabetes mellitus: a systematic review and dose–response meta-analysis of prospective cohort studies

Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling

A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice

Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities

Erratum to: Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice

Metabolic coupling in pancreatic beta cells: lipolysis revisited

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page